# Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid Overload

> **NCT03359161** · PHASE2,PHASE3 · TERMINATED · sponsor: **Steward St. Elizabeth's Medical Center of Boston, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **COMBINATION_PRODUCT:** sc2Wear Furosemide Infusor

## Key facts

- **NCT ID:** NCT03359161
- **Lead sponsor:** Steward St. Elizabeth's Medical Center of Boston, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-05
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Development of first generation device discontinued.
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359161, "Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid Overload". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03359161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*